You need to sign in or sign up before continuing.
Clinical lung cancer
-
Clinical lung cancer · Sep 2007
Randomized Controlled TrialPrognostic factors in stage III non-small-cell lung cancer.
The aim of this study is to present an analysis investigating the association of patient characteristics with overall survival (OS) in individuals with stage III non-small-cell lung cancer (NSCLC). ⋯ This analysis suggests that FEV(1) > 2 L and higher pretreatment Hb values are associated with improved OS in patients with stage III NSCLC. These factors can be useful in predicting for more favorable outcomes in patients with stage III NSCLC and provide additional information when designing future studies.